3-iodobenzylguanidine has been researched along with carvedilol in 17 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 14 (82.35) | 29.6817 |
| 2010's | 3 (17.65) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fujimura, M; Ishida, Y; Komamura, K; Miyatake, K; Nakatani, S; Yamagishi, M; Yasumura, Y | 1 |
| Agostini, D; Amar, MH; Belin, A; Bouvard, G; Darlas, Y; Grollier, G; Hamon, M; Potier, JC | 1 |
| Kondo, C; Kusakabe, K; Momma, K; Nakajima, Y; Nakazawa, M; Toyono, M | 1 |
| Hirao, K; Iwado, Y; Kohno, M; Kondo, I; Matsuo, H; Mizushige, K; Nozaki, S; Senda, S | 1 |
| Hanatani, A; Hirooka, K; Hori, M; Ishida, Y; Komamura, K; Miyatake, K; Nakatani, S; Yamagishi, M; Yasumura, Y | 1 |
| Aizawa, Y; Ashino, H; Fuse, K; Kodama, M; Nakazawa, M; Takahashi, T; Tanabe, N; Tazawa, S; Wahed, MI; Watanabe, K | 1 |
| Castaigne, A; Dubois-Randé, JL; Hittinger, L; Merlet, P | 1 |
| Hamada, M; Hara, Y; Matsunaka, T; Nakata, S; Ogimoto, A; Ohtsuka, T; Saeki, H; Shigematsu, Y; Suzuki, J | 1 |
| Acar, P; Maunoury, C; Sidi, D | 1 |
| Adachi, H; Hoshizaki, H; Isobe, N; Naito, S; Oshima, S; Seki, R; Taniguchi, K; Toyama, T | 1 |
| Inoue, A; Yamashina, S; Yamazaki, J | 1 |
| Horie, M; Masuda, D; Matsumoto, T; Matsuo, S; Nakae, I | 1 |
| Bocchi, EA; Chizzola, PR; Gonçalves de Freitas, HF; Mansur, JA; Marinho, NV; Meneghetti, JC | 1 |
| Hatori, T; Ichikawa, S; Kasama, S; Kumakura, H; Kurabayashi, M; Sumino, H; Suzuki, T; Takayama, Y; Toyama, T | 1 |
| Azevedo, JC; Barbirato, GB; Coimbra, A; Dohmann, HF; Freire, Fde L; Mesquita, CT; Mesquita, ET; Miranda, SM; Nóbrega, AC; Ribeiro, ML | 1 |
| Bakx, A; de Peuter, OR; Kamphuisen, PW; Kok, WE; Meijers, JC; Nieuwland, R; Schaap, MC; Somsen, GA; van den Bogaard, B; Verberne, HJ | 1 |
| de Azevedo, JC; Mesquita, CT; Mesquita, ET; Messias, LR; Miranda, SM; Moscavitch, SD; Pereira, SB; Ribeiro, GS; Rodrigues, RC | 1 |
7 trial(s) available for 3-iodobenzylguanidine and carvedilol
| Article | Year |
|---|---|
Comparative left ventricular functional and neurohumoral effects of chronic treatment with carvedilol versus metoprolol in patients with dilated cardiomyopathy.
Topics: 3-Iodobenzylguanidine; Adrenergic beta-Antagonists; Adult; Atrial Natriuretic Factor; Carbazoles; Cardiomyopathy, Dilated; Carvedilol; Chronic Disease; Female; Hemodynamics; Humans; Male; Metoprolol; Middle Aged; Natriuretic Peptide, Brain; Neurotransmitter Agents; Norepinephrine; Propanolamines; Therapeutic Equivalency; Tomography, Emission-Computed, Single-Photon; Ventricular Function, Left | 2001 |
Use of thallium-201 myocardial scintigraphy for the prediction of the response to beta-blocker therapy in patients with dilated cardiomyopathy.
Topics: 3-Iodobenzylguanidine; Adrenergic beta-Antagonists; Adult; Aged; Carbazoles; Cardiomyopathy, Dilated; Carvedilol; Female; Forecasting; Heart; Hemodynamics; Humans; Male; Metoprolol; Middle Aged; Multivariate Analysis; Probability; Propanolamines; Radionuclide Imaging; Radiopharmaceuticals; Thallium Radioisotopes; Treatment Outcome | 2002 |
Use of 123I-MIBG scintigraphy to assess the impact of carvedilol on cardiac adrenergic neuronal function in childhood dilated cardiomyopathy.
Topics: 3-Iodobenzylguanidine; Adolescent; Adrenergic alpha-Antagonists; Adrenergic Fibers; Carbazoles; Cardiomyopathy, Dilated; Carvedilol; Child; Child, Preschool; Female; Gated Blood-Pool Imaging; Humans; Infant; Male; Propanolamines; Radiopharmaceuticals; Treatment Outcome; Ventricular Dysfunction, Left | 2003 |
Efficacy of carvedilol treatment on cardiac function and cardiac sympathetic nerve activity in patients with dilated cardiomyopathy: comparison with metoprolol therapy.
Topics: 3-Iodobenzylguanidine; Adrenergic Antagonists; Adult; Aged; Carbazoles; Cardiomyopathy, Dilated; Carvedilol; Female; Heart Ventricles; Humans; Male; Metoprolol; Middle Aged; Propanolamines; Radionuclide Imaging; Radiopharmaceuticals; Sympathetic Nervous System; Technetium Tc 99m Sestamibi; Treatment Outcome; Ventricular Dysfunction, Left | 2003 |
The effect of beta-adrenergic receptor antagonism in cardiac sympathetic neuronal remodeling in patients with heart failure.
Topics: 3-Iodobenzylguanidine; Adrenergic beta-Antagonists; Adult; Carbazoles; Cardiomyopathy, Dilated; Carvedilol; Double-Blind Method; Female; Heart Failure; Heart Ventricles; Humans; Male; Middle Aged; Norepinephrine; Propanolamines; Radionuclide Imaging; Radiopharmaceuticals; Sympathetic Nervous System; Treatment Outcome; Ventricular Dysfunction, Left | 2006 |
Evaluation of cardiac sympathetic nerve activity and left ventricular remodelling in patients with dilated cardiomyopathy on the treatment containing carvedilol.
Topics: 3-Iodobenzylguanidine; Adrenergic beta-Antagonists; Adult; Aged; Blood Pressure; Carbazoles; Cardiomyopathy, Dilated; Carvedilol; Echocardiography; Female; Heart; Heart Rate; Humans; Male; Middle Aged; Natriuretic Peptide, Brain; Propanolamines; Prospective Studies; Radiopharmaceuticals; Stroke Volume; Sympathetic Nervous System; Tomography, Emission-Computed, Single-Photon; Ventricular Remodeling | 2007 |
Differential effects of nonselective versus selective β-blockers on cardiac sympathetic activity and hemostasis in patients with heart failure.
Topics: 3-Iodobenzylguanidine; Adrenergic beta-Antagonists; Aged; Carbazoles; Carvedilol; Female; Haplotypes; Heart; Heart Failure; Hemostasis; Humans; Male; Metoprolol; Middle Aged; Patient Selection; Propanolamines; Radionuclide Imaging; Receptors, Adrenergic, beta-2; Sympathetic Nervous System; Treatment Outcome | 2013 |
10 other study(ies) available for 3-iodobenzylguanidine and carvedilol
| Article | Year |
|---|---|
Improvement in left ventricular function in response to carvedilol is accompanied by attenuation of neurohumoral activation in patients with dilated cardiomyopathy.
Topics: 3-Iodobenzylguanidine; Adrenergic beta-Antagonists; Adult; Aged; Atrial Natriuretic Factor; Biomarkers; Carbazoles; Cardiomyopathy, Dilated; Carvedilol; Female; Heart Ventricles; Humans; Male; Middle Aged; Natriuretic Peptide, Brain; Norepinephrine; Propanolamines; Radiopharmaceuticals; Recovery of Function; Retrospective Studies; Stroke Volume; Tomography, Emission-Computed, Single-Photon; Treatment Outcome; Ventricular Function, Left | 2000 |
Improvement of cardiac neuronal function after carvedilol treatment in dilated cardiomyopathy: a 123I-MIBG scintigraphic study.
Topics: 3-Iodobenzylguanidine; Adolescent; Adrenergic Antagonists; Adult; Aged; Aged, 80 and over; Carbazoles; Cardiomyopathy, Dilated; Carvedilol; Female; Heart; Humans; Iodine Radioisotopes; Male; Middle Aged; Propanolamines; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Stroke Volume; Sympathetic Nervous System; Vasodilator Agents | 2000 |
Effects of carvedilol on left ventricular function, mass, and scintigraphic findings in isolated left ventricular non-compaction.
Topics: 3-Iodobenzylguanidine; Adrenergic beta-Antagonists; Carbazoles; Carvedilol; Echocardiography; Fatty Acids; Heart Defects, Congenital; Humans; Infant; Iodobenzenes; Magnetic Resonance Imaging; Male; Propanolamines; Stroke Volume; Tomography, Emission-Computed, Single-Photon; Ventricular Function, Left | 2001 |
Ultrasonic tissue characterization can predict beta-blocker efficacy in dilated cardiomyopathy.
Topics: 3-Iodobenzylguanidine; Adrenergic beta-Antagonists; Carbazoles; Cardiomyopathy, Dilated; Carvedilol; Case-Control Studies; Dobutamine; Echocardiography, Doppler; Female; Heart; Humans; Iodine Radioisotopes; Male; Middle Aged; Propanolamines; Sensitivity and Specificity; Tomography, Emission-Computed, Single-Photon | 2001 |
Effects of carvedilol on cardiac function and cardiac adrenergic neuronal damage in rats with dilated cardiomyopathy.
Topics: 3-Iodobenzylguanidine; Adrenergic beta-Antagonists; Adrenergic Fibers; Animals; Autoimmune Diseases; Autoradiography; Carbazoles; Cardiomyopathy, Dilated; Carvedilol; Fibrosis; Heart; Hemodynamics; Male; Myocarditis; Myocardium; Organ Size; Propanolamines; Radionuclide Imaging; Radiopharmaceuticals; Rats; Rats, Inbred Lew; Vasodilator Agents | 2002 |
Myocardial adrenergic dysinnervation in dilated cardiomyopathy: cornerstone or epiphenomenon?
Topics: 3-Iodobenzylguanidine; Adrenergic beta-Antagonists; Adrenergic Fibers; Animals; Carbazoles; Cardiomyopathy, Dilated; Carvedilol; Heart; Myocarditis; Propanolamines; Radionuclide Imaging; Radiopharmaceuticals; Rats | 2002 |
The effect of beta-blocker on hamster model BIO 53.58 with dilated cardiomyopathy determined using 123I-MIBG myocardial scintigraphy.
Topics: 3-Iodobenzylguanidine; Adrenergic beta-Antagonists; Animals; Carbazoles; Cardiomyopathy, Dilated; Carvedilol; Cricetinae; Disease Models, Animal; Dose-Response Relationship, Drug; Metoprolol; Propanolamines; Radionuclide Imaging; Radiopharmaceuticals; Severity of Illness Index; Treatment Outcome | 2003 |
Dilated cardiomyopathy relieved as a result of beta-blocker therapy: a case report--key points in assessment of prognosis based on MIBG myocardial scintigraphy and BNP levels.
Topics: 3-Iodobenzylguanidine; Adrenergic beta-Antagonists; Carbazoles; Cardiomyopathy, Dilated; Carvedilol; Follow-Up Studies; Humans; Middle Aged; Natriuretic Peptide, Brain; Prognosis; Propanolamines; Radiopharmaceuticals; Severity of Illness Index; Tomography, Emission-Computed, Single-Photon; Treatment Outcome | 2005 |
Effects of short-term carvedilol on the cardiac sympathetic activity assessed by 123I-MIBG scintigraphy.
Topics: 3-Iodobenzylguanidine; Adrenergic beta-Antagonists; Adrenergic Fibers; Adult; Aged; Carbazoles; Carvedilol; Female; Heart; Heart Failure, Systolic; Humans; Male; Middle Aged; Propanolamines; Prospective Studies; Radionuclide Imaging; Radiopharmaceuticals; Stroke Volume; Time Factors; Treatment Outcome | 2010 |
Heart failure patients with B1-adrenoreceptor polymorphisms have augmented carvedilol response as detected by cardiac I123-MIBG scintigraphy.
Topics: 3-Iodobenzylguanidine; Adrenergic beta-Antagonists; Carbazoles; Carvedilol; Female; Heart Failure; Humans; Male; Middle Aged; Polymorphism, Genetic; Propanolamines; Radionuclide Imaging; Radiopharmaceuticals; Receptors, Adrenergic, beta-1 | 2014 |